Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Drugs Made In Amer Acqutn Co (DMAAR)

35 + Investors. Track Smart Money conviction in DMAAR. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
1Q ▲
Buyers last Q
48%

Smart Money Signals — DMAAR

Based on 35 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added DMAAR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
35 hedge funds hold DMAAR right now — the highest count in 2.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +84% more funds vs a year ago

fund count last 6Q
+16 new funds entered over the past year (+84% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 48% buying

13 buying14 selling
Last quarter: 14 funds reduced or exited vs 13 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~7 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 7 → 12 → 3 → 7. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 54% entered in last year

■ 0% conviction (2yr+) ■ 46% medium ■ 54% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Price up while funds trimmed (+1964% value, -11% shares)

Value
+1964%
Shares
-11%
Last quarter: total value of institutional DMAAR holdings rose +1964% even though funds reduced share count by 11%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
⚠️

Saturation — most institutions already know this story

19 → 7 → 12 → 3 → 7 new funds/Q
New funds entering each quarter: 7 → 12 → 3 → 7. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
🌱

Early stage — 100% of holders entered in last year

■ 0% veterans ■ 0% 1-2yr ■ 100% new
Of 35 current holders: 35 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 99% AUM from top-100 funds

99% from top-100 AUM funds
2 of 35 holders are among the 100 largest funds by AUM, controlling 99% of total institutional value in DMAAR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
5.1
out of 10
Moderate Exit Risk
Exit risk score 5.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DMAAR

In 2026 Q1, 13 hedge funds were net buyers of DMAAR (7 opened a new position, 6 added to an existing one), while 14 reduced or exited (10 trimmed, 4 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. 99% of total institutional value in DMAAR is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 35.

Hedge Fund Ownership: DMAAR

How many hedge funds hold DMAAR — quarterly history vs. share price
Quarterly hedge fund ownership of DMAAR vs. share price

Market Analysis: DMAAR

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DMAAR

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Drugs Made In Amer Acqutn Co (DMAAR) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much DMAAR has moved relative to its sector benchmark (SPY) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 90d ago
DMAAR
+73.8%
SPY
+12.4%

DMAAR outperformed SPY by +61.4% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 45d ago
DMAAR
-22.2%
SPY
-1.1%

Since the filing became public, DMAAR outperformed SPY by -21.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

1 top-rated funds 0 high-conviction
Consensus
1.3
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: DMAAR
35 + Investors

Track Smart Money conviction in DMAAR. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 35 32 9.38%
13F Shares 15M 17M -11.33%
Total Value $63M $3M 1963.99%
New Positions 7 3 +4
Increased Positions 6 4 +2
Closed Positions 4 3 +1
Reduced Positions 10 6 +4
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: DMAAR

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

35 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DMAAR. Verified SEC 13F-HR filings.

QUARTER:
Top 25 DMAAR holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 RLH Capital LLC 0.01% 399,391 $24K
2 Mangrove Partners IM, LLC 0.00% 850,000 $51K
3 Alpine Global Management, LLC 0.00% 362,500 $22K
4 Quarry LP 0.00% 249,391 $15K
5 Polar Asset Management Partners Inc. 0.00% 1,900,000 $114K
6 Highbridge Capital Management LLC 0.00% 1,044,319 $63K
7 Rivernorth Capital Management, LLC 0.00% 417,998 $25K
8 Westchester Capital Management, LLC 0.00% 500,000 $28K
9 Shaolin Capital Management LLC 0.00% 450,000 $27K
10 Radcliffe Capital Management, L.P. 0.00% 231,551 $13K
11 Meteora Capital, LLC 0.00% 182,581 $11K
12 Lineage Point Capital LP 0.00% 50,000 $3K
13 Bulldog Investors, LLP 0.00% 43,364 $3K
14 DLD Asset Management, LP 0.00% 101,594 $6K
15 Boothbay Fund Management, LLC 0.00% 695,227 $42K
16 Periscope Capital INC. 0.00% 75,000 $4K
17 GABELLI & Co INVESTMENT ADVISERS, INC. 0.00% 48,100 $3K
18 Wolverine Asset Management LLC 0.00% 693,136 $42K
19 AQR Arbitrage LLC 0.00% 372,322 $21K
20 Aristeia Capital, L.L.C. 0.00% 264,168 $16K
21 Hudson Bay Capital Management LP 0.00% 1,701,546 $94K
22 Whitebox Advisors LLC 0.00% 400,000 $24K
23 Context Capital Management, LLC 0.00% 201,016 $12K
24 Clear Street Group Inc. 0.00% 711,917 $43K
25 StoneX Group Inc. 0.00% 42,120 $3K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Drugs Made In Amer Acqutn Co (DMAAR)

What does the Smart Money Trend signal show for DMAAR?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added DMAAR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for DMAAR?

More sellers than buyers — 48% buying: Last quarter: 14 funds reduced or exited vs 13 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for DMAAR holders?

Elite ownership — 99% AUM from top-100 funds: 2 of 35 holders are among the 100 largest funds by AUM, controlling 99% of total institutional value in DMAAR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held DMAAR?

Mostly new holders — 54% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Drugs Made In Amer Acqutn Co (DMAAR) following the 2026 Q1 hedge fund 13F filings?

As of today, DMAAR has moved -22.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to -1.1% for the SPY sector ETF — an outperformance of -21.1%. Since the quarter end (March 31, 2026), DMAAR has gained +73.8% vs +12.4% for SPY. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →